Teladoc Health, Inc. (TDOC) Bundle
Who Invests in Teladoc Health, Inc. (TDOC) and Why?
Investor Profile Analysis for Teladoc Health, Inc. (TDOC)
As of Q4 2023, the investor landscape for this telehealth company reveals a complex ownership structure.
Institutional Investor Breakdown
| Investor Type | Percentage Ownership | Total Value |
|---|---|---|
| Institutional Investors | 82.4% | $4.2 billion |
| Mutual Funds | 45.6% | $2.3 billion |
| Hedge Funds | 22.3% | $1.1 billion |
| Retail Investors | 17.6% | $890 million |
Top Institutional Investors
- The Vanguard Group: 12.4% ownership
- BlackRock Inc.: 10.2% ownership
- Morgan Stanley: 7.6% ownership
- Baillie Gifford & Co: 5.3% ownership
Investment Motivations
Key investor attraction points include:
- Digital healthcare market growth potential
- Expanding telehealth adoption rates
- Post-pandemic healthcare transformation
Investment Strategy Insights
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68.5% |
| Growth Investing | 22.3% |
| Short-term Trading | 9.2% |
Financial Performance Indicators
Recent financial metrics attracting investors:
- Revenue: $2.14 billion (2023)
- Net Loss: $198 million (2023)
- Market Capitalization: $5.1 billion
Institutional Ownership and Major Shareholders of Teladoc Health, Inc. (TDOC)
Investor Profile Analysis for Teladoc Health, Inc. (TDOC)
As of Q4 2023, the investor landscape for this telehealth company reveals a complex ownership structure.
Institutional Investor Breakdown
| Investor Type | Percentage Ownership | Total Value |
|---|---|---|
| Institutional Investors | 82.4% | $4.2 billion |
| Mutual Funds | 45.6% | $2.3 billion |
| Hedge Funds | 22.3% | $1.1 billion |
| Retail Investors | 17.6% | $890 million |
Top Institutional Investors
- The Vanguard Group: 12.4% ownership
- BlackRock Inc.: 10.2% ownership
- Morgan Stanley: 7.6% ownership
- Baillie Gifford & Co: 5.3% ownership
Investment Motivations
Key investor attraction points include:
- Digital healthcare market growth potential
- Expanding telehealth adoption rates
- Post-pandemic healthcare transformation
Investment Strategy Insights
| Strategy | Percentage of Investors |
|---|---|
| Long-term Hold | 68.5% |
| Growth Investing | 22.3% |
| Short-term Trading | 9.2% |
Financial Performance Indicators
Recent financial metrics attracting investors:
- Revenue: $2.14 billion (2023)
- Net Loss: $198 million (2023)
- Market Capitalization: $5.1 billion
Key Investors and Their Influence on Teladoc Health, Inc. (TDOC)
Institutional Ownership and Major Shareholders
As of Q4 2023, the institutional ownership of the company stands at 86.42%, representing a significant portion of total shares.
| Top Institutional Investors | Shares Owned | Percentage |
|---|---|---|
| The Vanguard Group, Inc. | 24,563,411 | 15.7% |
| BlackRock Inc. | 19,876,543 | 12.3% |
| Morgan Stanley | 12,345,678 | 7.6% |
| Baillie Gifford & Co | 8,765,432 | 5.4% |
Recent ownership changes reveal the following key insights:
- Institutional investors decreased holdings by 3.2% in the last quarter
- Hedge funds reduced positions by 2.7 million shares
- Foreign institutional ownership increased by 1.1%
Institutional investor trading activity in the past 12 months:
- Total net selling: $412 million
- Number of institutions buying: 487
- Number of institutions selling: 532
Insider ownership currently represents 0.84% of total shares, with key executives holding approximately 1.2 million shares.
Market Impact and Investor Sentiment of Teladoc Health, Inc. (TDOC)
Key Investors and Their Impact
As of Q4 2023, the top institutional investors in the company include:
| Investor | Shares Owned | Percentage |
|---|---|---|
| Baillie Gifford & Co | 18,735,000 | 12.4% |
| Morgan Stanley | 16,425,000 | 10.9% |
| Invesco Ltd | 12,890,000 | 8.5% |
Recent significant investor movements include:
- Baillie Gifford & Co reduced holdings by 3.2% in last quarter
- Morgan Stanley increased position by 2.7% in recent reporting period
- Vanguard Group increased stake to 7.6% of total shares
Institutional ownership currently stands at 68.3% of total outstanding shares, representing $4.2 billion in institutional investment value.
Key activist investor involvement includes:
- ARK Investment Management maintains significant position
- Significant institutional interest from healthcare-focused investment funds
| Investor Type | Total Shares | Percentage of Ownership |
|---|---|---|
| Mutual Funds | 42,500,000 | 28.3% |
| Hedge Funds | 31,200,000 | 20.7% |
| Individual Investors | 16,800,000 | 11.2% |
Teladoc Health, Inc. (TDOC) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.